The Developing Medicines through Open Science (DMOS) program offers support and partnership opportunities for preclinical and clinical drug development in areas where open sharing and collaboration are key to advancement and where market solutions are limited.
This program aims to foster collaborations that undertake preclinical and clinical work to develop drug candidates in areas of unmet medical need, establish proof of concept (POC) for an open science path to drug development and further translate innovations into affordable medicines, generate economic activity, and support small and medium-sized enterprises (SMEs) in Canada.
For any program-related questions, write to Senior Program Manager, Resham Chhabra.
